Glutathione Supplements: Do They Raise Blood Levels?

Categories
Articles
Supplement Science Lab Interpretation 2026 Update Patient-Friendly

Oral glutathione can raise red-cell glutathione in some people, but a single serum result is rarely a reliable measure of antioxidant status. The useful clinical question is usually why glutathione demand is high and whether liver, kidney, nutrition, medication, or illness clues need attention.

📖 ~11 minutes 📅
📝 Published: 🩺 Medically Reviewed: ✅ Evidence-Based
⚡ Quick Summary v1.0 —
  1. Direct oral glutathione at 500 mg daily increased erythrocyte glutathione by roughly 30% to 35% in one 6-month randomized trial of healthy adults.
  2. Liposomal glutathione may improve absorption, but human trials remain small and do not prove better clinical outcomes than standard reduced glutathione.
  3. Whole-blood glutathione is more informative than serum for research-style testing, yet laboratories use different collection tubes, stabilizers, and reference intervals.
  4. GSH:GSSG ratio can be distorted within minutes if the specimen is not processed correctly; it should not be used alone to diagnose “oxidative stress.”
  5. N-acetylcysteine (NAC) supplies cysteine, the usual rate-limiting amino acid for glutathione synthesis; common non-prescription doses are 600 mg once or twice daily.
  6. No universal low cutoff exists for a glutathione blood level in routine clinical care, so an out-of-range private-lab result needs method-specific interpretation.
  7. Urgent assessment is safer than self-treatment for jaundice, confusion, persistent vomiting, dark urine, severe weakness, or suspected acetaminophen overdose.
  8. Core labs matter more than a glutathione score: CBC, liver panel, creatinine/eGFR, glucose or HbA1c, albumin, and targeted nutrient tests often reveal the actionable cause.

Do glutathione supplements meaningfully increase blood levels?

Yes, a glutathione supplement can raise measured glutathione, particularly red-cell glutathione, but the effect is variable and a higher result does not automatically mean better health. As of July 26, 2026, the most credible human data support a modest increase after sustained oral dosing rather than a dramatic same-day change. In my experience, people are often sold a “detox number” when what they really need is a careful look at liver function, nutrition, medicines, and symptoms.

Three-dimensional glutathione molecule beside a stabilized laboratory sample for glutathione supplement testing
Figure 1: Glutathione molecules and stabilized cellular sample illustrate why measured levels depend on handling.

A randomized trial by Richie et al. found that 500 mg of oral reduced glutathione daily increased erythrocyte glutathione by about 30% to 35% over 1 to 6 months in healthy adults (Richie et al., 2015). That is a real biological signal, although the study did not show that every participant gained fewer infections, less fatigue, or a longer life. NAC and glutathione evidence is often more relevant when cysteine intake or oxidative demand is the issue.

Glutathione is mainly inside cells, where it exists largely in its reduced form, GSH; blood plasma contains very little and is technically fragile. A 52-year-old endurance runner may have a transiently lower red-cell GSH after a hard event without having a deficiency disease, particularly if the sample was drawn after poor sleep, calorie restriction, and heavy training.

Dr. Thomas Klein’s clinical view is simple: treat a result as a clue, not a diagnosis. Kantesti is an AI blood test analyzer that puts supplement-related findings beside standard laboratory patterns, because a normal-looking glutathione result cannot exclude liver injury, anaemia, diabetes, or malabsorption.

Oral, liposomal, and reduced glutathione: what differs?

Standard oral reduced glutathione has the best direct trial evidence for raising red-cell stores, while liposomal products have plausible absorption advantages but thinner outcome evidence. The label form matters less than the dose, product quality, baseline nutrition, and whether the body can synthesize and recycle GSH.

Liposomal glutathione particles surrounding reduced glutathione molecules in a scientific visualization
Figure 2: Lipid vesicles can protect glutathione during digestion, but human evidence remains limited.

Reduced glutathione is the active tripeptide made from glutamate, cysteine, and glycine. In the Richie trial, 500 mg per day outperformed lower doses for erythrocyte measures; doses above 1,000 mg daily have not been shown to deliver proportionally larger clinical benefits. Patients comparing options should also see our supplement testing plan rather than changing five products at once.

A small 4-week study of liposomal glutathione reported increases in glutathione-related markers, with effects differing by paraoxonase-1 genotype (Sinha et al., 2018). The evidence here is honestly mixed: liposomal delivery may reduce digestive breakdown, but no convincing head-to-head trial has established that it prevents chronic disease better than ordinary oral glutathione.

Sublingual, acetylated, and “setria” formulations are marketed aggressively, yet they should not be considered interchangeable laboratory interventions. A supplement containing 250 mg per capsule cannot be assumed to behave like 500 mg of stabilized GSH, and a multivitamin review by age can uncover overlapping selenium, zinc, or vitamin C doses that complicate the plan.

Why a swallowed glutathione capsule may not equal a blood increase

A swallowed glutathione capsule does not travel intact into every cell; digestion, intestinal transport, liver metabolism, and cellular recycling determine the eventual effect. This is why two people taking the same 500 mg dose can show very different test results.

Digestive pathway illustration showing oral glutathione breakdown and absorption through intestinal cells
Figure 3: Digestion and cellular transport separate an oral dose from intracellular glutathione status.

Intestinal enzymes can split GSH into amino acids and smaller peptides before absorption, after which cells may rebuild it. The limiting substrate is often cysteine, not glutamate; that is the biochemical reason NAC is used in hospital toxicology and in some research protocols. It is also why a direct glutathione product may disappoint in someone with poor protein intake or ongoing inflammation.

The liver exports glutathione into bile and blood and uses it in many conjugation reactions, so hepatobiliary disease can alter the picture without producing a neatly “low GSH” report. A raised ALT with bilirubin or alkaline phosphatase deserves a conventional work-up first; our guide to liver-panel components explains the pattern clinicians actually use.

Red cells contain millimolar concentrations of glutathione, whereas plasma concentrations are much lower and fall quickly if cells break down after collection. The distinction between serum, plasma, and whole blood is not semantics—see what serum means—because each matrix answers a different biological question.

Which glutathione blood tests are clinically useful?

Whole-blood or erythrocyte GSH measured by a laboratory that immediately stabilizes the sample is usually more meaningful than a serum glutathione blood level. Even then, no major UK, US, or European guideline recommends routine glutathione testing to screen healthy adults.

Laboratory specialist preparing a stabilized whole-blood sample for glutathione and oxidized glutathione analysis
Figure 4: Immediate specimen stabilization is necessary for meaningful reduced and oxidized glutathione testing.

A laboratory should state whether it measured reduced GSH, oxidized glutathione (GSSG), total glutathione, or the GSH:GSSG ratio, and should publish its own method-specific interval. Whole-blood GSH often lies in the low millimolar range, while plasma GSH is generally measured in micromolar units; a number without matrix and units is not interpretable. Our biomarker reference guide helps distinguish specialized markers from routine tests.

The GSH:GSSG ratio is biologically interesting because oxidation converts two GSH molecules into GSSG, but it is pre-analytically vulnerable. Delayed centrifugation, temperature changes, haemolysis, and missing thiol-blocking reagents can create an artificially low ratio within a short handling window—one of those areas where context matters more than the number.

Kantesti is an AI blood test interpretation platform that reads a specialized glutathione result alongside its specimen type, collection conditions, liver enzymes, kidney function, and blood count. A private test that only says “low antioxidant capacity” is not equivalent to validated whole-blood GSH by HPLC or mass spectrometry.

How should you interpret a low glutathione result?

A low glutathione result is not a diagnosis, because laboratories have no single universal cutoff and pre-analytical error is common. A repeat sample collected under the same conditions is often more valuable than immediately doubling a supplement dose.

Clinical comparison of properly stabilized and delayed laboratory samples used for glutathione measurement
Figure 5: Collection delays can change glutathione measurements before the laboratory analysis begins.

Start by checking the report for specimen type, unit, reference interval, fasting status, time to processing, and whether you had taken glutathione, NAC, vitamin C, alcohol, or intense exercise beforehand. A reference interval represents a laboratory population, not an individual target; our explanation of out-of-range flags can prevent unnecessary alarm.

A repeat result that remains below the same laboratory interval alongside low albumin, anaemia, raised CRP, or abnormal ALT has more clinical weight than an isolated low GSH. Conversely, an isolated value after a viral illness, marathon, overnight fast, or poor sample handling usually calls for a calmer recheck rather than a “detox” protocol.

Some European laboratories report lower erythrocyte ranges than North American specialty laboratories because assay calibration and storage differ. The practical rule is to compare serial results only when the same method, laboratory, supplement dose, and collection timing are used.

When do low stores point to an underlying medical problem?

Persistently low or abnormal glutathione markers warrant medical evaluation when they occur with liver disease, chronic kidney disease, malnutrition, malabsorption, uncontrolled diabetes, heavy alcohol exposure, or symptoms of systemic illness. Low GSH alone does not identify which of these is present.

Anatomically accurate liver and kidney models beside glutathione assay equipment in a medical laboratory
Figure 6: Liver and kidney function strongly influence glutathione production, recycling, and elimination pathways.

The liver produces and recycles substantial amounts of glutathione, so AST, ALT, alkaline phosphatase, bilirubin, albumin, and INR often matter more than a specialized antioxidant panel. Jaundice, dark urine, pale stool, new abdominal swelling, or confusion require prompt medical assessment, not self-directed supplements; see the warning signs in liver supplement safety.

Kidney impairment can alter oxidative-stress markers and limits safe use of several products. An eGFR below 60 mL/min/1.73 m² persisting for at least 3 months meets the chronic kidney disease definition, and urine albumin testing helps stage risk; our CKD stages guide gives the clinical context.

Kantesti is an AI-powered blood test analysis tool that flags clusters such as low albumin, elevated bilirubin, falling eGFR, and anaemia for clinician review rather than declaring “glutathione deficiency.” Our approach and guardrails are described in medical validation, which matters because an algorithm cannot diagnose unexplained symptoms.

Are NAC, glycine, and other precursors more effective?

NAC is often more physiologically sensible than direct glutathione when cysteine availability is limiting, but it does not reliably raise every person’s measured GSH. Glycine can also matter, especially in older adults or people with low overall protein intake.

Molecular illustration of NAC and glycine providing building blocks for intracellular glutathione synthesis
Figure 7: Cysteine from NAC and glycine can support the three-part glutathione synthesis pathway.

NAC provides cysteine after absorption and is an established antidote pathway for acetaminophen toxicity under medical supervision. Non-prescription regimens commonly use 600 mg once or twice daily, but nausea, reflux, and loose stools become more common as doses rise. A 2023 Cochrane review supports acetylcysteine in acetaminophen poisoning, not as a general-purpose longevity supplement (Chiew et al., 2023).

Glycine plus NAC, often called GlyNAC, has shown promising metabolic and glutathione-synthesis signals in small studies of older adults, but these trials are too small to prescribe it as disease prevention. A food-first discussion is reasonable when dietary protein is low; our mineral deficiency testing guide explains why zinc, magnesium, and iron claims should be checked rather than guessed.

Alpha-lipoic acid, selenium, riboflavin, and vitamin C are sometimes marketed as glutathione “recyclers.” Selenium deficiency is uncommon in many regions, and excessive supplemental selenium can cause hair changes, gastrointestinal symptoms, and neuropathy; more is not better here.

Can food raise glutathione status without a supplement?

Adequate protein, regular energy intake, and micronutrient sufficiency support glutathione synthesis more reliably than chasing a single “glutathione-rich” food. Food-derived glutathione itself is variably digested, but its amino-acid building blocks are useful.

Whole foods rich in glutathione precursors arranged with a small laboratory sample vial on slate
Figure 8: Protein foods and plant sources supply amino acids needed to make glutathione internally.

Adults without kidney or liver dietary restrictions generally need enough protein to cover nitrogen and cysteine needs; a practical minimum is often around 0.8 g/kg/day, while older adults or athletes may need more depending on health and training. Lentils, eggs, dairy, soy foods, fish, poultry, nuts, and seeds can all contribute, with no need for an exotic powder.

Sulfur-containing vegetables such as broccoli, cabbage, and onions contain compounds that may influence phase-II enzyme activity, but they do not replace treatment for diagnosed liver disease. People following strict plant-based diets should consider a focused review of B12, iron, zinc, and protein adequacy; our plant-based diet lab guide is a sensible starting point.

Alcohol can increase oxidative demand and disrupt nutrition even when a person’s supplement routine is excellent. If GGT, ALT, triglycerides, or MCV are changing, the more revealing intervention is usually a period without alcohol and a planned recheck, as outlined in post-alcohol biomarker trends.

Should you stop glutathione before a blood test?

For a direct glutathione measurement, do not take a new dose immediately before the draw unless the ordering clinician specifically wants a post-dose value. For standard liver, kidney, CBC, glucose, and lipid tests, disclose all supplements rather than stopping prescribed treatment on your own.

Overhead clinical layout showing supplement capsule, timed laboratory sample kit, and exercise watch without labels
Figure 9: Dose timing, exercise, fasting, and collection handling can all influence glutathione-related testing.

A conservative approach is to hold non-essential glutathione or NAC for 24 to 48 hours before a baseline specialized test, document the pause, and use the same timing at follow-up. This is a consistency convention, not a universal laboratory rule; the ordering lab’s instructions override it. Fasting and supplement effects are especially relevant when other assays are being drawn together.

Avoid unusually hard exercise for 24 to 48 hours before a baseline oxidative-stress draw if your aim is to compare resting status. Resistance training can also raise CK and AST from muscle, which can make a liver interpretation look more concerning than it is; review exercise-related laboratory shifts if that happens.

Do not stop NAC that has been prescribed for a respiratory, psychiatric, or other clinical indication merely to obtain a cleaner number. The result should serve the patient, not the other way around.

Who should be cautious with glutathione and NAC supplements?

People who are pregnant, breastfeeding, receiving cancer treatment, managing asthma, taking anticoagulants, or living with advanced kidney or liver disease should discuss glutathione or NAC with a clinician before use. The main danger is often delay of diagnosis or an interaction, rather than glutathione itself.

Pharmacist reviewing a supplement bottle beside medication organizer and liver-function laboratory requisition
Figure 10: Medication review helps identify when supplement use needs clinician oversight.

NAC can cause nausea, abdominal discomfort, diarrhoea, and a sulfur-like smell; inhaled NAC can provoke bronchospasm in susceptible people, although this is different from ordinary oral use. People using nitroglycerin should seek advice because NAC may enhance vasodilation and cause headache or low blood pressure.

During cancer treatment, supplement decisions should be coordinated with the oncology team because antioxidant effects can be therapy-specific and timing-dependent. There is no credible rule that every antioxidant is harmful or helpful during chemotherapy—the regimen, cancer type, dose, and evidence matter. Our chemo laboratory-change guide explains why trends need specialist context.

A product marketed as “liposomal” is not automatically purer or safer, and multi-ingredient detox blends are a recurring source of preventable liver injury. Choose products with a disclosed amount per serving and avoid stacking several formulas that contain NAC, selenium, zinc, or high-dose vitamin C.

When should low glutathione lead to medical evaluation instead of self-treatment?

Seek medical care rather than self-treating if a low glutathione result accompanies jaundice, confusion, fever, unexplained weight loss, swollen legs, persistent vomiting, severe abdominal pain, or rapidly worsening fatigue. These symptoms can signal liver, kidney, blood, endocrine, infectious, or gastrointestinal disease that a supplement will not fix.

Clinician reviewing abnormal liver and kidney laboratory patterns on a tablet beside a patient information card
Figure 11: A low specialized marker gains meaning when paired with actionable routine laboratory abnormalities.

Suspected acetaminophen overdose is an emergency regardless of any home glutathione product. Hospital protocols use timed acetaminophen concentrations, liver tests, INR, creatinine, and medically supervised acetylcysteine; waiting for a glutathione blood level could be dangerous.

Persistent diarrhoea, unintended weight loss, iron deficiency, low albumin, or recurrent mouth ulcers raise the possibility of malabsorption or inflammatory bowel disease. In that setting, focus on diagnosis—coeliac testing, stool studies, and nutritional assessment may be appropriate—rather than assuming oxidative stress is the root cause.

Kantesti can organize results from a photo or PDF and identify combinations worth discussing, but it does not replace urgent care. If privacy is a concern before sharing reports, use our safe upload checklist and remove information you do not need to submit.

What is a sensible before-and-after testing plan?

A useful supplement trial starts with routine safety labs, one clearly defined product, and a repeat assessment after 8 to 12 weeks—not daily testing and not a dozen simultaneous changes. Red-cell glutathione, if tested, changes more slowly than a transient plasma value.

Sequential laboratory sample containers and calendar markers arranged as a clinical follow-up pathway
Figure 12: A stable baseline and an 8-to-12-week follow-up make supplement effects easier to interpret.

Before starting, record symptoms, supplement brand and dose, alcohol intake, exercise pattern, and a baseline CBC, comprehensive metabolic panel, creatinine/eGFR, fasting glucose or HbA1c, and nutrition tests directed by diet or symptoms. A fasting glucose of 100 to 125 mg/dL indicates impaired fasting glucose, while 126 mg/dL or higher on confirmatory testing suggests diabetes; this finding deserves attention independent of glutathione.

At 8 to 12 weeks, repeat only the tests that answer the original question and use the same laboratory where possible. Dr. Thomas Klein has seen more confusion from switching laboratories and changing diet, exercise, alcohol, and four supplements in the same month than from any genuinely mysterious biology; trend analysis principles help separate signal from noise.

Stop the trial and seek review if ALT rises to more than 3 times the laboratory upper limit of normal, bilirubin rises, eGFR falls substantially, or new symptoms appear. A 10% laboratory fluctuation without symptoms is often less important than a coherent multi-marker pattern.

How Kantesti interprets glutathione results in laboratory context

Kantesti interprets a glutathione result as supportive context, not as a standalone diagnosis, by comparing it with routine markers and prior results. That prevents a specialized assay from overshadowing a potentially more urgent abnormality such as anaemia, elevated bilirubin, or declining kidney function.

Secure clinical workstation comparing glutathione result with longitudinal liver kidney and blood-count patterns
Figure 13: Pattern comparison places specialized glutathione testing beside standard laboratory safety markers.

Kantesti is an AI lab test interpretation service designed to identify meaningful clusters across uploaded laboratory reports, including liver enzymes, bilirubin, albumin, eGFR, CBC indices, glucose, and inflammatory markers. A low GSH with normal safety labs may support a measured lifestyle experiment; the same result with a falling albumin should prompt a clinician conversation.

Our analysis also looks for changes over time, because a value that moved 25% after a consistent 500 mg daily dose is more interpretable than one isolated result. This does not establish cause and effect, but it gives a doctor a cleaner history. Readers can meet the clinicians who oversee this work through our Medical Advisory Board.

Do not use an AI report to decide that jaundice, chest pain, fainting, confusion, or overdose symptoms can wait. Those are symptom-led decisions, and no normal glutathione result makes them safe to ignore.

A practical decision rule for glutathione supplements

Consider a glutathione supplement only after clarifying the goal, checking for medical red flags, and deciding how you will measure a meaningful response. For most otherwise healthy adults, 500 mg daily of reduced glutathione or 600 mg daily of NAC is a reasonable discussion point, not a mandatory long-term treatment.

Clinical decision scene with glutathione supplement, routine laboratory results, and liver and kidney anatomy models
Figure 14: A supplement choice should follow safety labs, symptoms, diet review, and a defined follow-up plan.

If your objective is general wellness and routine tests are normal, a time-limited 8-to-12-week trial with stable diet and training is more defensible than escalating doses indefinitely. If your objective is fatigue, brain fog, skin changes, or recurrent illness, first look for common and treatable contributors such as iron deficiency, thyroid disease, diabetes, sleep problems, depression, medication effects, or infection.

A glutathione blood level is most useful when the laboratory method is clear and the result fits a broader clinical question. It is least useful when used as a verdict on whether your body is “toxic,” because that phrase has no accepted laboratory definition.

Kantesti’s clinical logic is explained in our AI technology guide: standardized result extraction, reference-aware interpretation, and trend comparison can support a better appointment, while diagnosis and treatment decisions remain with the qualified clinician who knows your history.

Frequently Asked Questions

Do glutathione supplements increase blood levels?

Oral reduced glutathione can increase erythrocyte glutathione levels in some adults. In a randomized trial, 500 mg daily raised red-cell glutathione by roughly 30% to 35% over 1 to 6 months, although the response varied between participants (Richie et al., 2015). A plasma glutathione result is less dependable because concentrations are low and specimen handling can alter the value quickly. Higher glutathione on a test does not by itself prove a clinical benefit.

Is liposomal glutathione better than regular glutathione?

Liposomal glutathione may improve delivery through the digestive tract, but there is not enough high-quality evidence to say it is clinically superior to standard reduced glutathione. A small 4-week human study found changes in glutathione-related measures, with responses differing by genotype (Sinha et al., 2018). Direct oral reduced glutathione at 500 mg daily has stronger longer-term red-cell data. Product quality, dose, diet, and the reason for supplementation are likely more important than marketing language.

What is a normal glutathione blood level?

There is no single normal glutathione blood level that applies across all laboratories because whole blood, red cells, plasma, and serum use different units and analytical methods. Whole-blood glutathione is often reported in millimolar concentrations, while plasma glutathione is commonly measured in micromolar concentrations. The GSH:GSSG ratio is also highly sensitive to delayed processing and cell breakdown. Use the reporting laboratory’s own reference interval and compare follow-up results only with the same method.

Should I take NAC or glutathione?

NAC is often the more logical option when low cysteine intake or increased glutathione demand is suspected, because cysteine is frequently rate-limiting for glutathione synthesis. Common non-prescription NAC doses are 600 mg once or twice daily, while direct reduced glutathione is commonly taken at 250 to 500 mg daily. NAC can cause nausea, reflux, or diarrhoea, and people using nitroglycerin, receiving cancer therapy, or managing complex illness should seek clinician advice. Neither product should be used to self-treat jaundice, confusion, or suspected acetaminophen overdose.

How long does it take glutathione supplements to work?

A meaningful change in erythrocyte glutathione is more likely to be assessed over 8 to 12 weeks than over a few days. The oral glutathione trial by Richie et al. observed increases at 1 month that persisted through 6 months at a 500 mg daily dose. Symptoms such as energy or skin appearance are nonspecific and should not be used as proof that a supplement corrected a biochemical problem. A stable routine and one planned repeat test provide a clearer answer than frequent testing.

Can a low glutathione result mean liver disease?

A low glutathione result can occur with liver stress or liver disease, but it cannot diagnose liver disease on its own. ALT, AST, alkaline phosphatase, bilirubin, albumin, INR, platelet count, symptoms, alcohol exposure, medicines, and imaging provide much more actionable information. Jaundice, dark urine, pale stool, abdominal swelling, or confusion require prompt medical evaluation regardless of a glutathione result. Do not use a glutathione supplement as a substitute for a liver assessment.

Get AI-Powered Blood Test Analysis Today

Join over 2 million users worldwide who trust Kantesti for instant, accurate lab test analysis. Upload your blood test results and receive comprehensive interpretation of 15,000+ biomarkers in seconds.

📚 Referenced Research Publications

1

Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti Editorial Team. (2026). Nipah Virus Blood Test: Early Detection & Diagnosis Guide 2026. Zenodo. https://doi.org/10.5281/zenodo.18487418. Kantesti AI Medical Research.

2

Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti Editorial Team. (2026). B Negative Blood Type, LDH Blood Test & Reticulocyte Count Guide. Figshare. https://doi.org/10.6084/m9.figshare.31333819. Kantesti AI Medical Research.

📖 External Medical References

3

Richie JP Jr et al. (2015). Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. European Journal of Nutrition.

4

Sinha R et al. (2018). Liposomal glutathione supplementation: influence on glutathione status and oxidative stress biomarkers in healthy adults. European Journal of Clinical Nutrition.

5

Chiew AL et al. (2023). Interventions for paracetamol (acetaminophen) overdose. Cochrane Database of Systematic Reviews.

2M+Tests Analyzed
127+Countries
75+Languages

⚕️ Medical Disclaimer

E-E-A-T Trust Signals

Experience

Physician-led clinical review of lab interpretation workflows.

📋

Expertise

Laboratory medicine focus on how biomarkers behave in clinical context.

👤

Authoritativeness

Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.

🛡️

Trustworthiness

Evidence-based interpretation with clear follow-up pathways to reduce alarm.

🏢 Kantesti LTD Registered in England & Wales · Company No. 17090423 London, United Kingdom · kantesti.net
blank
By Prof. Dr. Thomas Klein

Dr. Thomas Klein is a board-certified clinical hematologist serving as Chief Medical Officer at Kantesti AI. With over 15 years of experience in laboratory medicine and a strong interest in AI-supported interpretation of blood test results, he works to connect new technology with everyday clinical practice. His areas of interest include biomarker analysis, clinical decision support research and population-specific reference range optimization. As CMO, he contributes clinical input to the platform's internal benchmarking and provides clinical oversight for the medical quality of Kantesti's educational reports.

Leave a Reply

Your email address will not be published. Required fields are marked *